Sommaire
Littérature scientifique sur le sujet « Interferon Gamma CXCL10 »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Interferon Gamma CXCL10 ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Interferon Gamma CXCL10"
Hameed, Ruaa Salim. « Upregulated CXCL10 gene Expression in SARS-CoV-2 Infected people ». BASRA JOURNAL OF SCIENCE 40, no 2 (1 septembre 2022) : 357–65. http://dx.doi.org/10.29072/basjs.20220208.
Texte intégralLim, JaeHyun, Steven C. Derrick, Kristopher Kolibab, Amy Li Yang, Steven Porcelli, William R. Jacobs et Sheldon L. Morris. « Early Pulmonary Cytokine and Chemokine Responses in Mice Immunized with Three Different Vaccines against Mycobacterium tuberculosis Determined by PCR Array ». Clinical and Vaccine Immunology 16, no 1 (26 novembre 2008) : 122–26. http://dx.doi.org/10.1128/cvi.00359-08.
Texte intégralSchnabel, Christiane L., Susanna Babasyan, Heather Freer et Bettina Wagner. « CXCL10 production in equine monocytes is stimulated by interferon-gamma ». Veterinary Immunology and Immunopathology 207 (janvier 2019) : 25–30. http://dx.doi.org/10.1016/j.vetimm.2018.11.016.
Texte intégralZaph, Colby, et Phillip Scott. « Interleukin-12 Regulates Chemokine Gene Expression during the Early Immune Response to Leishmania major ». Infection and Immunity 71, no 3 (mars 2003) : 1587–89. http://dx.doi.org/10.1128/iai.71.3.1587-1589.2003.
Texte intégralColvin, Richard A., Gabriele S. V. Campanella, Lindsay A. Manice et Andrew D. Luster. « CXCR3 Requires Tyrosine Sulfation for Ligand Binding and a Second Extracellular Loop Arginine Residue for Ligand-Induced Chemotaxis ». Molecular and Cellular Biology 26, no 15 (1 août 2006) : 5838–49. http://dx.doi.org/10.1128/mcb.00556-06.
Texte intégralScollard, David M., Meher V. Chaduvula, Alejandra Martinez, Natalie Fowlkes, Indira Nath, Barbara M. Stryjewska, Michael T. Kearney et Diana L. Williams. « Increased CXC Ligand 10 Levels and Gene Expression in Type 1 Leprosy Reactions ». Clinical and Vaccine Immunology 18, no 6 (20 avril 2011) : 947–53. http://dx.doi.org/10.1128/cvi.00042-11.
Texte intégralChai, Qingqing, Ruiping She, Ying Huang et Zhen F. Fu. « Expression of Neuronal CXCL10 Induced by Rabies Virus Infection Initiates Infiltration of Inflammatory Cells, Production of Chemokines and Cytokines, and Enhancement of Blood-Brain Barrier Permeability ». Journal of Virology 89, no 1 (22 octobre 2014) : 870–76. http://dx.doi.org/10.1128/jvi.02154-14.
Texte intégralSvensson, Mattias, Soombul Zubairi, Asher Maroof, Fatima Kazi, Masaru Taniguchi et Paul M. Kaye. « Invariant NKT Cells Are Essential for the Regulation of Hepatic CXCL10 Gene Expression during Leishmania donovani Infection ». Infection and Immunity 73, no 11 (novembre 2005) : 7541–47. http://dx.doi.org/10.1128/iai.73.11.7541-7547.2005.
Texte intégralJauregui, Catherine E., Qian Wang, Christopher J. Wright, Hiroki Takeuchi, Silvia M. Uriarte et Richard J. Lamont. « Suppression of T-Cell Chemokines by Porphyromonas gingivalis ». Infection and Immunity 81, no 7 (15 avril 2013) : 2288–95. http://dx.doi.org/10.1128/iai.00264-13.
Texte intégralAsensio, Valérie C., Joachim Maier, Richard Milner, Kaan Boztug, Carrie Kincaid, Maxime Moulard, Curtis Phillipson et al. « Interferon-Independent, Human Immunodeficiency Virus Type 1 gp120-Mediated Induction of CXCL10/IP-10 Gene Expression by Astrocytes In Vivo and In Vitro ». Journal of Virology 75, no 15 (1 août 2001) : 7067–77. http://dx.doi.org/10.1128/jvi.75.15.7067-7077.2001.
Texte intégralThèses sur le sujet "Interferon Gamma CXCL10"
Allen, Frederick Jr. « CCL3 Augments Antitumor Responses in CT26 by Enhancing Cellular Trafficking and Interferon-Gamma Expression ». Case Western Reserve University School of Graduate Studies / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=case1513124234665339.
Texte intégralLOCATELLI, LUIGI. « Expression of aVB6 integrin by Pkhd1-defective cholangiocytes links enhanced ductal secretion of Macrophage chemokines to progressive portal fibrosis in Congenital Hepatic Fibrosis ». Doctoral thesis, Università degli Studi di Milano-Bicocca, 2013. http://hdl.handle.net/10281/41733.
Texte intégralVIEIRA, DANIEL P. « Avaliação dos efeitos da inibição de cadeias imflamatórias e da suplementação exógena de CXCL 12 na hematopoiese de modelos experimentais expostos a doses letais ou subletais de radiação gama ». reponame:Repositório Institucional do IPEN, 2007. http://repositorio.ipen.br:8080/xmlui/handle/123456789/11618.
Texte intégralMade available in DSpace on 2014-10-09T14:09:29Z (GMT). No. of bitstreams: 0
Tese (Doutoramento)
IPEN/T
Instituto de Pesquisas Energéticas e Nucleares - IPEN-CNEN/SP
Huang, Mei-Liang, et 黃美椋. « Analysis of human interferon-gamma-inducible protein 10 (IP-10)/CXCL10 promoter polymorphism at position -938 ». Thesis, 2007. http://ndltd.ncl.edu.tw/handle/95334133739233112603.
Texte intégral臺灣大學
流行病學研究所
95
Introduction - Interferon-γ inducible protein 10 (IP-10)/CXCLl10 was shown to be an indicator of disease progress for severe acute respiratory syndrome (SARS); a high plasma level in the early clinical stage was associated with subsequent adverse outcome. The mechanism that triggers CXCL10 expression in SARS-CoV infection is still unknown. Method - We conducted a genetic epidemiological study to identify the single nucleotide polymorphism (SNP) of CXCL10 that might be associated with severe SARS clinical outcomes. With luciferase assay and electromobility shift assay (EMSA), we conducted in vitro functional study of the polymorphic alleles of CXCL10 promoter with the attempt to identify the regulatory factors for CXCL10 expression. Results - Five SNPs of CXCL10 were typed for 108 SARS patients along with 242 healthy control DNAs. A genotype TT at the CXCL10(-938) SNP locus was identified to correlate with severity of SARS-CoV infected patients, especially among SARS patients with a detectably higher nasopharyngeal virus load. DNA fragment of the 996 bp upstream of the CXCL10 start codon containing either (-938C) or (-938T) SNP was cloned into the luciferase reporter pGL3 vector along with a series of 5’ end truncated CXCL10 promoter DNA fragments. With IFN-γ stimulation in A549 cell and HMEC-1 cells, the shortest two fragments (-704, and -413) showed a high luciferase activity, which dropped with each increment of the 5’ end DNA length; stimulation with IFN-γ and TNF-α in combination induced a higher luciferase activity, but the drop of activity was reversed with the fragment of -704 and -996, suggesting possibly IFN-γ associated negative regulation factors and TNF-α associated positive regulation factors could bind to this region. The difference of luciferase activity between the two alleles of CXCL10(-996C) and CXCL10(-996T) could not be consistently demonstrated, however. We used nuclear extracts from IFN-γ induced THP-1 cells and the 32P-labeled probes of CXCL10(-928~-948) promoter sequence containing (-938C) or (-938T) and antibodies against a number of TFs antibodies to perform EMSA. The (-938C) probe consistently binds to more nuclear proteins than the (-938T) probe, and three putative binding proteins, YY-1, MZF and Pax-6, of CXCL10 (-938) were found to reduce the shifted band in EMSA and supershift assay. The activation functions of YY-1 and MZF on CXCL10 expression were demonstrated by luciferase assay and the results showed YY-1 and MZF could trigger the activation of CXCL10, however, YY-1 and MZF induced activity were not different between the two alleles. Conclusion - The genotype TT of CXCL10 (-938) SNP was associated with adverse outcome of SARS patient. The DNA sequence flanking the CXCL10 (-938) SNP locus possibly contain binding motifs of YY-1, MZF and Pax-6. However, the functional difference between these two alleles of CXCL10 (-938) could not be demonstrated in vitro by luciferase assay and EMSA in the study.
Heinz, Torsten Joseph. « Immunreaktionen im zentralen Nervensystem bei Stimulation mit Bestandteilen von Borrelia burgdorferi ». Doctoral thesis, 2014. http://hdl.handle.net/11858/00-1735-0000-0022-60A8-B.
Texte intégralActes de conférences sur le sujet "Interferon Gamma CXCL10"
Kernder, Anna, Johanna Mucke, Long Tang-Chieu, Torsten Lowin, Tim Claßen, Oliver Sander, Ellen Bleck et al. « AB0125 CXCL17 IN RHEUMATOID ARTHRITIS : INTERFERONE-GAMMA INDUCIBLE EXPRESSION AND INHIBITION OF ANGIOGENESIS ». Dans Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.6571.
Texte intégral